SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-021393
Filing Date
2021-04-13
Accepted
2021-04-13 16:19:26
Documents
45
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0221_oramedpharmaceutica.htm 10-Q 442215
2 SECOND AMENDMENT, DATED FEBRUARY 8, 2021, TO EMPLOYMENT AGREEMENT, ENTERED INTO f10q0221ex10-1_oramedpharma.htm EX-10.1 10105
3 CERTIFICATION f10q0221ex31-1_oramedpharma.htm EX-31.1 13779
4 CERTIFICATION f10q0221ex31-2_oramedpharma.htm EX-31.2 13825
5 CERTIFICATION f10q0221ex32-1_oramedpharma.htm EX-32.1 5601
6 CERTIFICATION f10q0221ex32-2_oramedpharma.htm EX-32.2 5627
  Complete submission text file 0001213900-21-021393.txt   2529612

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE ormp-20210228.xml EX-101.INS 326082
8 XBRL SCHEMA FILE ormp-20210228.xsd EX-101.SCH 31813
9 XBRL CALCULATION FILE ormp-20210228_cal.xml EX-101.CAL 28085
10 XBRL DEFINITION FILE ormp-20210228_def.xml EX-101.DEF 152441
11 XBRL LABEL FILE ormp-20210228_lab.xml EX-101.LAB 309034
12 XBRL PRESENTATION FILE ormp-20210228_pre.xml EX-101.PRE 155271
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 21823300
SIC: 2834 Pharmaceutical Preparations